引用次数
引用: 29,328
H-指数: 89
I10-指数 : 262
出版物: 760
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, May 2020, In: Gastroenterology. 158, 6, p. 1682-1697. e1 Research output: Contribution to journal› Article
D Temelkovski , J Nulsen , J Perner , M Cereda
Nature Communications 9 3857 -3857
2018
Loss of SRY-box2 (SOX2) expression predicts adverse survival of patients with esophageal adenocarcinoma
FJC ten Kate , SH van Olphen , MJ Bruno , BPL Wijnhoven
Advances in Barrett’s Esophagus Surveillance and Improved Prediction of Prognosis and Therapy Response in Patients with Esophageal Adenocarcinoma 149 -149
2017
A new, biologically relevant classification for adenocarcinoma at the gastroesophageal junction
J Bornschein , J Perner , L Wernisch , M Secrier
29th International Workshop on Helicobacter and Microbiota in Inflammation and Cancer
2016
C-MYC AS A BIOMARKER IN BARRETT'S OESOPHAGUS
S Varghese , CS Ross-Innes , P Lao-Sirieix , M O'Donovan
GUT 62 A119 -A119
2013
DEFINING CANCER RISK IN BARRETT'S OESOPHAGUS USING A 90-GENE SIGNATURE
S Varghese , R Newton , CS Ross-Innes , KK Krishnadath
GUT 62 A12 -A12
2013
THE COMBINATION OF AUTOFLUORESCENCE IMAGING AND PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY HAS AN EXCELLENT DIAGNOSTIC ACCURACY FOR DYSPLASIA IN BARRETT'S ESOPHAGUS
M Di Pietro , E Bird-Lieberman , X Liu , M O'Donovan
GUT 62 A111 -A112
2013
PTU-172 C-Myc as a Biomarker in Barrett’S Oesophagus
S Varghese , CS Ross-Innes , P Lao-Sirieix , M O’Donovan
Gut 62 ( Suppl 1) A119 -A119
2013
PWE-020 Using microarray data to elucidate the molecular phenotype of a novel oncogene and identify a therapeutic strategy
CA J Ong , NB Shannon , OM Rueda , R Hardwick
Gut 61 ( Suppl 2) A305 -A305
2012
PTU-218 Pilot randomised cross-over study comparing the efficacy of transnasal Endosheath® to standard endoscopy to detect Barrett's oesophagus
KM Shariff , S Verghese , M O'Donovan , Z Abdullahi
Gut 61 ( Suppl 2) A274 -A274
2012
A CLINICALLY APPLICABLE THREE GENE SIGNATURE IS INDEPENDENTLY HIGHLY PROGNOSTIC IN OESOPHAGEAL AND JUNCTIONAL ADENOCARCINOMA
CJ Peters , JRE Rees , JS Hardwick , SL Vowler
GUT 59 A24 -A25
2010
OC-060 A clinically applicable three gene signature is independently highly prognostic in oesophageal and junctional adenocarcinoma
CJ Peters , JRE Rees , JS Hardwick , SL Vowler
Gut 59 ( Suppl 1) A24 -A25
2010
PTU-019 Nasal or standard endoscopy (nose) for diagnosis of Barrett's oesophagus–efficacy and patient tolerance
KM Shariff , EL Bird-Lieberman , M O'Donovan , Z Abdullahi
Gut 59 ( Suppl 1) A56 -A56
2010
PERSONALISING CHEMOTHERAPY TO IMPROVE OESOPHAGOGASTRIC CANCER OUTCOMES
AL Paterson , TM Gilmer , RF Wooster , RC Fitzgerald
GUT 58 A31 -A32
2009
CDX2-DEPENDENT HOX GENE REGULATION IN BARRETT'S OESOPHAGUS
M di Pietro , RC Fitzgerald
GUT 58 A142 -A143
2009
A potential role for periostin in barrett's carcinogenesis
A Saadi , M Das , N Clemons , C Zhang
GUT 57 A128 -A128
2008
An improved staging system for oesophageal adenocarcinoma based on the number of involved lymph nodes
CJ Peters , RH Hardwick , JRE Rees , SL Vowler
GUT 57 A13 -A14
2008
EGFR and erbb2 phosphorylation status: Implications for erbb targeted therapies
AL Paterson , HZ Shi , L Liu , TM Gilmer
GUT 57 A127 -A128
2008
EMT in esophageal adenocarcinoma
JRE Rees , BA Onwuegbusi , VE Save , D Alderson
CANCER RESEARCH 67 ( 1) 427 -427
2007
Reactive oxygen species induced DNA damage in oesophageal adenocarcinoma
NJ Clemons , RC Fitzgerald
GUT 55 A21 -A21
2006
The bile acid, lithocholic acid, activates retinoid signaling in Barrett's oesophageal cell lines
C Chang , RC Fitzgerald
GUT 55 A105 -A106
2006